Ginossar Ventures

Illumex provides a generative semantic platform that optimizes structured data for analytics and governance in generative AI. The platform automatically analyzes metadata to discover, label, and add semantic meaning and business context without altering the underlying data. It offers data and analytics mapping, interpretation, and governance through a domain-specific AI engine that supports trustworthy, governed, and customized organizational large language models. By contextualizing organizational knowledge, Illumex helps enterprises harness big data for decision intelligence, promote data democratization, and improve return on investment.

GlossAI specializes in transforming long-form video content into engaging short clips using AI-driven automation. Its platform enables organizations and individuals to efficiently edit and distribute their pre-recorded content across various channels.

DeepSurface is a cybersecurity company headquartered in Portland, Oregon, specializing in risk-based vulnerability management. It offers a platform that automates the analysis and prioritization of vulnerabilities for cybersecurity teams. Utilizing advanced rules and an extensive collection of over 50 environmental attributes, DeepSurface contextualizes vulnerabilities and their potential chains to predict areas of greatest risk for organizations. This enables teams to effectively prioritize their efforts and measure vulnerability risk with proven methodologies. Trusted by enterprise-level clients, DeepSurface aims to enhance the efficiency of cybersecurity operations by providing clear insights into where adversaries could inflict the most damage.

Yonalink operates a global network comprising over 30,000 medical centers. It specializes in real-time collection of clinical trial data through its platform, which streamlines electronic health records (EHR) to electronic data capture (EDC), employs AI-driven case report form (CRF) data mapping, and facilitates secure, automated migration of research data from health records. This service enhances trial efficiency, improves data quality, reduces staff burnout at medical centers, and expands access to novel patient care opportunities. Additionally, the platform enables management of clinical trial operations and vendors, accelerates drug and device development, promotes patient diversity and enrollment, and ensures secure, fast, and error-free data capture processes for healthcare providers and researchers.